Pediatric rheumatology

Three‐Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular Juvenile Idiopathic Arthritis (JIA) Consensus Treatment Plans Study

Arthritis RheumatolPublished Prospective cohort study

Authors' conclusion

EC was superior to SU across three years for outcomes reflecting time spent in lower disease activity. Starting bDMARD within two months predicted rapid improvement and maintenance of inactive disease.

Study context

Population
STOP-JIA participants with polyarticular JIA and Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry follow-up through three years
Participants
297 participants
Exposure
Step-up vs early combination vs biologic first treatment plans in polyarticular JIA
  • SUn = 190reference
  • ECn = 76
  • Biologic firstn = 31
Outcome
ACR clinically inactive disease (CID) off GC
Follow-up
Three-year visit
Methodological detailsconsensus treatment plans, CARRA Registry follow-up, latent class trajectory modeling
  • Consensus treatment plans
  • CARRA Registry follow-up
  • Latent class trajectory modeling

Main finding

As reported in the abstract

P = 0.35 for SU versus EC

Observational data: associations, not effects.

Further findings

OutcomeSUECP value
Clinical remission on medication (CRM)EC vs SU40.6%59.9%P = 0.012
Time spent in CIDEC vs SU30%38%P = 0.04
cJADAS-10-ID (cJADAS-10 ≤ 2.5)EC vs SU41%51%P = 0.02

Rapid improvement trajectory (latent class trajectory modeling (LCTM)) by timing of biologic disease-modifying antirheumatic drug (bDMARD) initiation

bDMARD initiation within first month from baseline, OR
5.33
bDMARD initiation within second month from baseline, OR
2.67
Slow, moderate and rapid improvement trajectories identified

Original publication

Three‐Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis Rheumatol. Published 7 July 2025. doi:10.1002/art.43216

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.